[go: up one dir, main page]

BR9910488A - Derivados do ácido hidroxâmico como antibacterianos - Google Patents

Derivados do ácido hidroxâmico como antibacterianos

Info

Publication number
BR9910488A
BR9910488A BR9910488-1A BR9910488A BR9910488A BR 9910488 A BR9910488 A BR 9910488A BR 9910488 A BR9910488 A BR 9910488A BR 9910488 A BR9910488 A BR 9910488A
Authority
BR
Brazil
Prior art keywords
alkyl
group
antibacterials
acid derivatives
hydroxamic acid
Prior art date
Application number
BR9910488-1A
Other languages
English (en)
Inventor
Michel George Hunter
Raymond Paul Beckett
John Martin Clements
Mark Whittaker
Zoe Marie Spavold
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of BR9910488A publication Critical patent/BR9910488A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DO áCIDO HIDROXâMICO COMO ANTIBACTERIANOS"<D>. Os compostos de fórmula (I) são antibacterianos em que: R~ 1~ representa hidrogênio ou C~ 1~-C~ 6~ alquila ou C~ 1~-C~ 6~ alquila substituída por um ou mais átomos halogênio; R~ 2~ representa um grupo R~ 10~-(X)~ n~-(ALK)~ m~- em que R~ 10~ representa hidrogênio ou um grupo C~ 1~-C~ 6~ alquila, C~ 2~-C~ 6~ alquenila, C~ 2~-C~ 6~ alquinila, cicloalquila, arila ou heterociclila, dos quais qualquer um pode ser não-substituído ou substituído por (C~ 1~-C~ 6~) alquila, (C~ 1~-C~ 6~) alcóxi, hidróxi, mercapto, (C~ 1~-C~ 6~) alquiltio, amino, halo (incluindo flúor, cloro, bromo e iodo), trifluorometila, ciano, nitro, -COOH, -CONH~ 2~, -COOR^ A^, -NHCOR^ A^, -CONHR^ A^, -NHR^ A^, -NR^ A^R^ B^ ou -CONR^ A^R^ B^ em que R^ A^ e R^ B^ são independentemente um grupo (C~ 1~-C~ 6~) alquila e ALK representa um radical C~ 1~-C~ 6~ alquileno, C~ 2~-C~ 6~ alquenileno ou C~ 2~-C~ 6~ alquinileno divalente reto ou ramificado e pode estar interrompido por um ou mais ligações -NH-, -O- ou -S- não adjacentes, X representa -NH-, -O- ou -S- e m e n são independentemente 0 ou 1; e A representa um grupo como definido na especificação.
BR9910488-1A 1998-05-16 1999-05-14 Derivados do ácido hidroxâmico como antibacterianos BR9910488A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810464.9A GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives
PCT/GB1999/001541 WO1999059568A1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials

Publications (1)

Publication Number Publication Date
BR9910488A true BR9910488A (pt) 2001-01-09

Family

ID=10832125

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910488-1A BR9910488A (pt) 1998-05-16 1999-05-14 Derivados do ácido hidroxâmico como antibacterianos

Country Status (23)

Country Link
US (3) US6441042B1 (pt)
EP (2) EP1079819B1 (pt)
JP (1) JP2002515427A (pt)
KR (1) KR100634089B1 (pt)
CN (1) CN1300210A (pt)
AT (1) ATE347356T1 (pt)
AU (1) AU754063B2 (pt)
BR (1) BR9910488A (pt)
CA (1) CA2332713C (pt)
CY (1) CY1106452T1 (pt)
DE (1) DE69934309T2 (pt)
DK (1) DK1079819T3 (pt)
ES (1) ES2278444T3 (pt)
GB (2) GB9810464D0 (pt)
HU (1) HUP0102290A3 (pt)
IL (2) IL139059A0 (pt)
NO (1) NO20005782L (pt)
NZ (1) NZ507560A (pt)
PL (1) PL344438A1 (pt)
PT (1) PT1079819E (pt)
TR (1) TR200003376T2 (pt)
WO (1) WO1999059568A1 (pt)
ZA (1) ZA200006131B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102901A3 (en) * 1998-02-07 2002-12-28 British Biotech Pharm Use of n-formyl hydroxylamines as antibacterial agents
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
ATE293600T1 (de) * 1999-08-10 2005-05-15 Vernalis Oxford Ltd Antibakterielle mittel
WO2001040198A2 (fr) * 1999-11-30 2001-06-07 Aventis Pharma S.A. Derives macrocycliques de l'acide hydroxamique et leur utilisation en tant qu'antimicrobiens
FR2801591B1 (fr) * 1999-11-30 2002-03-01 Aventis Pharma Sa Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent
GB9929979D0 (en) * 1999-12-17 2000-02-09 Darwin Discovery Ltd Hydroxamic acid derivatives
AU2268401A (en) * 1999-12-17 2001-06-25 Versicor Inc Novel succinate compounds, compositions and methods of use and preparation
AU2002230385A1 (en) * 2000-09-25 2002-04-15 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
EP1339400B1 (en) * 2000-11-23 2005-06-29 Vernalis (Oxford) Ltd N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
JP2004532826A (ja) * 2001-03-19 2004-10-28 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ （ｓ，ｒ，ｒ）−（−）−アクチノニンおよびそのアナログの不斉合成、ならびにそれらの使用
WO2002081426A1 (en) * 2001-04-05 2002-10-17 Smithkline Beecham Corporation Peptide deformylase inhibitors
GB0128943D0 (en) * 2001-12-04 2002-01-23 Novo Pharmaceuticals De Ltd Bacterial enzyme inhibitors
JP4190862B2 (ja) * 2001-12-18 2008-12-03 シャープ株式会社 表示装置およびその駆動方法
GB0208579D0 (en) * 2002-04-13 2002-05-22 British Biotech Pharm Antibacterial agents
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
WO2009070736A1 (en) * 2007-11-29 2009-06-04 Inolex Investment Corporation Preservatives for cosmetic, toiletry and pharmaceutical compositions
DE102011088962A1 (de) * 2011-12-19 2013-06-20 Beiersdorf Ag Wirkstoffkombinationen aus einer oder mehreren Carbonsäuren, insbesondereHydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologische Zubereitungen, solcheWirkstoffkombinationen enthaltend
WO2016201288A1 (en) 2015-06-12 2016-12-15 Brown University Novel antibacterial compounds and methods of making and using same
KR102431631B1 (ko) * 2017-06-29 2022-08-11 킴벌리-클라크 월드와이드, 인크. 디히드록삼산을 포함하는 항균 조성물 및 이를 이용한 미생물 생장 억제 방법
CN108672095A (zh) * 2018-05-04 2018-10-19 广东省资源综合利用研究所 γ-羟基烷基羟肟酸及其制备方法与应用
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028921A (en) * 1962-01-23 1966-05-11 Ranjeet Bhagwan Singh New antibiotic
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
JPH0670019B2 (ja) * 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質ｓｆ２１９７ｃ物質およびその製造法
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
JPH03157372A (ja) * 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Ｙｌ―０１８６９ｐ物質及びその製造法
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
NZ271893A (en) * 1993-08-23 1997-11-24 Immunex Corp Inhibitors of tnf-alpha secretion
JP3157372B2 (ja) 1993-11-29 2001-04-16 三洋電機株式会社 フィルタ
ATE182581T1 (de) * 1994-06-22 1999-08-15 British Biotech Pharm Metalloproteinase-inhibitoren
US5532265A (en) 1994-11-30 1996-07-02 The Board Of Trustees Of The Leland Stanford Junior University Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
GB9507799D0 (en) * 1995-04-18 1995-05-31 British Biotech Pharm Metalloproteinase inhibitors
US6281245B1 (en) * 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
ES2239787T3 (es) * 1996-12-06 2005-10-01 Fonden Til Fremme Af Eksperimentel Cancerforskning Inhibicion de invasion remodeladora.
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
HUP0102901A3 (en) * 1998-02-07 2002-12-28 British Biotech Pharm Use of n-formyl hydroxylamines as antibacterial agents
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives

Also Published As

Publication number Publication date
ZA200006131B (en) 2002-01-30
HUP0102290A3 (en) 2001-12-28
US6441042B1 (en) 2002-08-27
CY1106452T1 (el) 2011-10-12
GB0024789D0 (en) 2000-11-22
US20020198241A1 (en) 2002-12-26
IL139059A (en) 2006-12-31
PT1079819E (pt) 2007-03-30
ES2278444T3 (es) 2007-08-01
US7323563B2 (en) 2008-01-29
AU3942199A (en) 1999-12-06
EP1079819B1 (en) 2006-12-06
US6992190B2 (en) 2006-01-31
HUP0102290A2 (hu) 2001-11-28
GB2353708A (en) 2001-03-07
GB9810464D0 (en) 1998-07-15
EP1079819A1 (en) 2001-03-07
JP2002515427A (ja) 2002-05-28
EP1754477A3 (en) 2007-03-14
CN1300210A (zh) 2001-06-20
PL344438A1 (en) 2001-11-05
IL139059A0 (en) 2001-11-25
US20060211732A1 (en) 2006-09-21
DE69934309D1 (de) 2007-01-18
KR100634089B1 (ko) 2006-10-17
TR200003376T2 (tr) 2001-03-21
KR20010034861A (ko) 2001-04-25
CA2332713C (en) 2008-04-01
NO20005782D0 (no) 2000-11-15
EP1754477A2 (en) 2007-02-21
AU754063B2 (en) 2002-10-31
WO1999059568A1 (en) 1999-11-25
NZ507560A (en) 2003-06-30
DE69934309T2 (de) 2007-07-05
NO20005782L (no) 2001-01-15
DK1079819T3 (da) 2007-04-10
CA2332713A1 (en) 1999-11-25
ATE347356T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
BR9910488A (pt) Derivados do ácido hidroxâmico como antibacterianos
BR9907689A (pt) Agentes antibacterianos
BR9812010A (pt) Determinados ácidos 5-alquil-2-arilaminofenilacéticos e derivados
BR0210028A (pt) Agentes antibacterianos
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR0215058A (pt) 2-fenil benzofuranos substituìdos como agentes estrogênicos
BR9916422A (pt) Saponinas antiprotozoárias
DE69920923D1 (de) Anthranilsäurederivate
BR9914158A (pt) Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
BR9606487A (pt) Processo para a preparação de um ácido aromático halossubstituído
BR0012327A (pt) Pirrolidinas e piperidinas neurotróficas, e composições e métodos relacionados
BR0009211A (pt) Derivados de resorcinol
DE69925882D1 (de) Aminosäurederivate als Entzündungshemmende Mittel
BR0015483A (pt) Feniluracilas substituìdas e sua aplicação como herbicidas
BR0011246A (pt) Processos para o preparo de novos derivados de propenona substituìda
BR9806102A (pt) Processo para o ajuste de uma mola de membrana.
BRPI0507344A (pt) composição de glifosato
BR9902219A (pt) Processo para alquilar sulfonamidas esteroquimicamente impedidas.
BR0214259A (pt) Composição aquosa de tratamento capilar, uso da mesma e método para tratamento dos cabelos
BR9813920A (pt) Trifluorometilbifenilil-dihalofenilazolinas como pesticidas
DK0654470T3 (da) Lagerstabile vandige opløsninger af isothiazolin-3-oner
TR199902807A2 (xx) 2-(tio ikameli)tiazolo-$4,5-b]piridin bile�iklerinin pestisit ve parasitisel kullan�m�.
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
BR9902525A (pt) Processo para compostos de ácido pirrolidinil-hidroxâmico

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.